Authors: Chen Li, Chen Song DOI: 10.3760/cma.j.issn.2095-0160.2016.07.020 Published 2016-07-10 Cite as Chin J Exp Ophthalmol, 2016,34(7): 667-671. Abstract [Download PDF] [Read Full Text] Diabetic retinopathy (DR) is one of the major complications of diabetes.It includes microvascular disease and neuronal function change.For the early treatment of DR, […]
Category: Review
Role of mitochondria in the optic neuropathy
Authors: Ji Kaibao, Zhang Xu DOI: 10.3760/cma.j.issn.2095-0160.2016.07.019 Published 2016-07-10 Cite as Chin J Exp Ophthalmol, 2016,34(7): 663-666. Abstract [Download PDF] [Read Full Text] Mitochondria are an important eukaryotic cell organelle with inner and outer membranes.They generate the necessary lifecycle energy for cells through aerobic respiration, and plays […]
Diode laser transscleral cyclophotocoagulation as a primary surgical treatment for glaucoma-questions and future
Authors: Zhang Shaodan, Liu Chi, Liang Yuanbo DOI: 10.3760/cma.j.issn.2095-0160.2016.07.018 Published 2016-07-10 Cite as Chin J Exp Ophthalmol, 2016,34(7): 658-662. Abstract [Download PDF] [Read Full Text] Cyclophotocoagulation is one of the efficacious procedures for the treatment of refractory glaucoma.However, its clinical utilization is limited due to severe […]
A review on selective laser trabeculoplasty
Authors: Zhang Hongyang, Yu Minbin DOI: 10.3760/cma.j.issn.2095-0160.2016.07.017 Published 2016-07-10 Cite as Chin J Exp Ophthalmol, 2016,34(7): 654-657. Abstract [Download PDF] [Read Full Text] Glaucoma is an irreversible blinding disease.The aim of glaucoma therapy is to lower the intraocular pressure (IOP), and then slow down glaucoma progression.Currently, […]
Current researches on effects of retinal neuroglial cells in glaucoma
Authors: Xue Bo, Ji Min, Guan Huaijin DOI: 10.3760/cma.j.issn.2095-0160.2016.07.016 Published 2016-07-10 Cite as Chin J Exp Ophthalmol, 2016,34(7): 649-653. Abstract [Download PDF] [Read Full Text] Glaucoma is a degenerative disease of the retina and the optic nerve.The apoptosis of retinal ganglion cells is the pathological basis […]
Recent advance about cytokines of proliferative vitreoretinopathy
Authors: Han Ruifang, Li Ningdong DOI: 10.3760/cma.j.issn.2095-0160.2016.08.021 Published 2016-08-10 Cite as Chin J Exp Ophthalmol, 2016,34(8): 765-768. Abstract [Download PDF] [Read Full Text] Proliferative vitreoretinopathy (PVR) is a leading cause of blindness and caused by abnormal repairs for the damaged vitreous and […]
Progress and prospect of treatment for ocular Behçet disease
Authors: Bai Lin, Yang Peizeng DOI: 10.3760/cma.j.issn.2095-0160.2016.08.020 Published 2016-08-10 Cite as Chin J Exp Ophthalmol, 2016,34(8): 761-764. Abstract [Download PDF] [Read Full Text] Ocular Behçet disease, which usually presents as panuveitis, with characteristic of vision impairment and relapse, is one of the most refractory uveitis entities.Usually, one […]
The pathological mechanism and clinical research of dendritic cells in the uveitis
Authors: Wang Beibei, Lin Wei, Bi Hongsheng DOI: 10.3760/cma.j.issn.2095-0160.2016.08.019 Published 2016-08-10 Cite as Chin J Exp Ophthalmol, 2016,34(8): 756-760. Abstract [Download PDF] [Read Full Text] Uveitis is mainly T helper cells (Th)-mediated autoimmune disease.It is one of the common eye diseases causing blindness.Dendritic cells (DCs), which are […]
Recent advances in the etiology of Posner-Schlossman syndrome
Authors:Sun Yanran, Dang Yalong, Zhang Chun DOI: 10.3760/cma.j.issn.2095-0160.2016.10.020 Published 2016-10-10 Cite as Chin J Exp Ophthalmol, 2016,34(10): 957-960. Abstract [Download PDF] [Read Full Text] Posner-Schlossman syndrome (PSS) or glaucomatocyclitic crisis is a rare, unilateral recurrent inflammatory ocular hypertensive disease.Although it is typically self-limited and has benign […]
Advance in gene therapy of ocular disease
Authors:Lyu Juling, Xing Yiqiao, Shen Yin DOI: 10.3760/cma.j.issn.2095-0160.2016.10.019 Published 2016-10-10 Cite as Chin J Exp Ophthalmol, 2016,34(10): 952-956. Abstract [Download PDF] [Read Full Text] Currently, 31 clinical trials have been approved, most of them are still in progress.Leber congenital amaurosis (LCA) has been conducted to phase […]